NeuBase Therapeutics, Inc. Operating Lease, Liability, Noncurrent
NeuBase Therapeutics, Inc. had Operating Lease, Liability, Noncurrent of $4.83 million as of 2023-09-30, per its 10-Q filed 2023-11-09.
Discontinued › Balance Sheet › Liabilities › Liabilities, Noncurrent › Liabilities, Other than Long-Term Debt, Noncurrent
us-gaap:OperatingLeaseLiabilityNoncurrent · last filed 2023-11-09
- 2023-09-30: Operating Lease, Liability, Noncurrent $4.83M.
- 2023-06-30: Operating Lease, Liability, Noncurrent $4.96M.
- 2023-03-31: Operating Lease, Liability, Noncurrent $5.09M.
- 2022-12-31: Operating Lease, Liability, Noncurrent $5.21M.
| Period end | Operating Lease, Liability, Noncurrent |
|---|---|
| 2023-09-30 | $4.83M 10-Q · filed 2023-11-09 |
| 2023-06-30 | $4.96M 10-Q · filed 2023-08-14 |
| 2023-03-31 | $5.09M 10-Q · filed 2023-05-11 |
| 2022-12-31 | $5.21M 10-Q · filed 2023-11-09 |
| 2022-09-30 | $5.34M 10-QT · filed 2023-06-05 |
| 2022-06-30 | $5.46M 10-Q · filed 2022-08-11 |
| 2022-03-31 | $5.61M 10-Q · filed 2022-05-12 |
| 2021-12-31 | $5.68M 10-Q · filed 2022-02-11 |
| 2021-09-30 | $5.79M 10-K · filed 2022-12-21 |
| 2021-06-30 | $5.90M 10-Q · filed 2021-08-13 |
| 2020-09-30 | $0.00 10-K · filed 2021-12-23 |